Glaucoma, Intraocular Pressure IOP, Alergic Drug Reactions

Understanding Glaucoma and Intraocular Pressure

Before examining specific case studies, it is essential to clarify the nature of glaucoma. It is a complex eye disease fundamentally related to the health and resiliency of the optic nerve. While elevated intraocular pressure (IOP) is a significant factor, it is not the sole diagnostic criterion for glaucoma. It is more accurately described as a risk factor; it is possible for an individual with low intraocular pressure to have glaucoma, just as it is possible for someone with high intraocular pressure to present with the condition. Distinguishing between eye pressure and the disease itself is critical for a proper understanding of ocular health.

Case Study: Managing Glaucoma and Allergic Reactions

This case involves a female patient in her 50s who was diagnosed with glaucoma in 2011. Her clinical presentation included high intraocular pressure and inferior rim thinning of the optic nerve in both the left and right eyes. In addition to her glaucoma, she was nearsighted and required corrective lenses. A significant complication arose when she began experiencing allergic skin reactions on her face and neck, triggered by the pharmaceutical drugs prescribed to manage her intraocular pressure.

To address these issues, the patient underwent 48 sessions of coMra therapy over a 28-day period in the autumn of 2016. Each session lasted approximately 20 minutes and utilized the Neurology 14 protocol.

Results and Clinical Observations

Following the course of coMra therapy, the patient attended a check-up in October 2016. The results were remarkable: her intraocular pressure had reached its lowest recorded level, measuring 14 mmHg in both the right and left eyes. Furthermore, the patient reported that after the first week of treatment, she experienced an increase in her field of vision, and the allergic skin rash had completely resolved.

When reviewing the patient's history, it is notable that she had previously undergone a trabeculoplasty in 2014 – a surgical procedure involving the creation of a small opening in the trabecular meshwork to reduce pressure. However, the surgical intervention provided only temporary relief, with pressure levels rising again shortly after the procedure.

During the coMra therapy period, the patient also utilized herbal supplements to support detoxification of the skin, kidneys, lymph, liver, and bowel, aiming to clear the residual chemicals from her previous glaucoma medications. She also incorporated specific eye-health supplements and general vitamins and minerals. It is important to note that coMra therapy works synergistically with other treatments, whether invasive or non-invasive, to improve overall health outcomes. While the patient continues to use one of her prescribed eye drops under the supervision of her medical doctor, the integration of coMra therapy has been instrumental in her progress.

Defining Optic Nerve Inferior Rim Thinning

In clinical terms, "inferior rim thinning" refers to the structural changes at the back of the eye. The optic disc, where the optic nerve enters the eye, shows thinning specifically at the bottom (inferior) portion of the rim. Monitoring these structural changes is a key component of managing the long-term health of the optic nerve.

As Théun Mares, the founder of Radiant Life Technologies, once noted: "The state of well-being is something that has to be experienced before one even knows that it exists. Once it has been discovered, it needs to be nurtured and tended with care."